Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Karuna Therapeutics Announces The Lancet Publication of Data from Phase 3 EMERGENT-2 Trial Evaluating KarXT in Schizophrenia | 1 | 270 | December 15, 2023 | |
| Karuna: NDA Filing Q3 Of 2023 And Expanded Potential With KarXT (NASDAQ:KRTX) | 0 | 367 | August 24, 2023 | |
| Karuna's stock jumps 42% after sharing promising Phase 3 data for its schizophrenia drug | 30 | 925 | August 13, 2022 | |
| EMERGENT Trial Data For KarXT Shows Promise in Schizophrenia | 3 | 426 | June 26, 2023 | |
| Karuna Therapeutics Submits NDA | 5 | 262 | September 28, 2023 |